8PL2 Stock Overview
Engages in the asset management activities. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
AKKO Invest Nyrt. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Ft0.75 |
52 Week High | Ft0.89 |
52 Week Low | Ft0.54 |
Beta | 0.25 |
1 Month Change | -3.36% |
3 Month Change | 12.65% |
1 Year Change | 34.05% |
3 Year Change | -27.80% |
5 Year Change | -35.52% |
Change since IPO | 706.07% |
Recent News & Updates
Recent updates
Shareholder Returns
8PL2 | DE Capital Markets | DE Market | |
---|---|---|---|
7D | -2.1% | -2.0% | -2.6% |
1Y | 34.1% | 21.1% | 6.9% |
Return vs Industry: 8PL2 exceeded the German Capital Markets industry which returned 21.1% over the past year.
Return vs Market: 8PL2 exceeded the German Market which returned 6.9% over the past year.
Price Volatility
8PL2 volatility | |
---|---|
8PL2 Average Weekly Movement | 6.4% |
Capital Markets Industry Average Movement | 4.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8PL2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 8PL2's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | 534 | n/a | www.akkoinvest.hu |
AKKO Invest Nyrt. engages in the asset management activities. The company was formerly known as Plotinus Holding Nyrt. and changed its name to AKKO Invest Nyrt.
AKKO Invest Nyrt. Fundamentals Summary
8PL2 fundamental statistics | |
---|---|
Market cap | €27.42m |
Earnings (TTM) | €4.22m |
Revenue (TTM) | €101.97m |
6.5x
P/E Ratio0.3x
P/S RatioIs 8PL2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8PL2 income statement (TTM) | |
---|---|
Revenue | Ft42.18b |
Cost of Revenue | Ft38.49b |
Gross Profit | Ft3.69b |
Other Expenses | Ft1.94b |
Earnings | Ft1.75b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 52.32 |
Gross Margin | 8.75% |
Net Profit Margin | 4.14% |
Debt/Equity Ratio | 122.2% |
How did 8PL2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 18:20 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AKKO Invest Nyrt. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Norbert Kalliwoda | Dr. Kalliwoda Research |